Full List Of Stories
Unilever says GSK consumer arm 'strategic fit', flags restructure
Unilever on Monday maintained it was still keen to buy GSK's consumer healthcare arm, calling it a "strong strategic fit", despite having its latest £50bn offer rejected as it also flagged a restructure of the group later this month.
NIESR forecasters to strike over below-inflation pay offer
Economic forecasters are set to stage a two-week walkout over, ironically, below-inflation pay offers.
Europe open: Unilever, GSK in spotlight as shares edge ahead
European stocks opened slightly higher on Monday as investors eyed Unilever’s attempts to buy the consumer health division of GSK.
Europe midday: Shares edge further ahead on Unilever bid for GSK assets
European edged further ahead at midday on Monday as investors eyed Unilever’s attempts to buy the consumer health division of GSK.
Former Labour City minister Paul Myners dies at 73
Former Labour City minister Paul Myners, a key figure in helping the UK respond to the bank-induced 2008 financial crisis, has died at the age of 73, his family said on Monday.
Tritax EuroBox buys Swedish asset
Logistics real estate investment company Tritax EuroBox said it had bought land in Sweden and agreed to fund the development of a logistics asset for SEK 402m (£32m).
Oxford Biomedica CEO John Dawson to step down
Oxford Biomedica chief executive John Dawson said he was stepping down after 13 years at the helm of the Gene and cell therapy firm which helped develop a Covid-19 vaccine with AstraZeneca.
Hikma buys Teligent Canadian assets for $47.75m
Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45. 75m after the US firm filed for Chapter 11 bankruptcy last year.